MRK vs SNDK: Which Is the Better Buy?

Side-by-side comparison of Merck & Co., Inc. and Sandisk Corporation โ€” fair value, conviction, valuation metrics, and QuantHub research signals. Updated 2026-09-18.
Merck & Co., Inc. ยท Healthcare
$147.17
-4.1% upside to fair value
Med Conviction Grade C
VS
Sandisk Corporation ยท Technology
$1,614.39
-25.3% upside to fair value
Med Conviction Grade C
QuantHub Verdict
MRK has more upside to fair value (-4.1%). These are model outputs โ€” not personalized investment advice. See all research โ†’
Valuation & Fundamentals
Metric MRK SNDK
Current Price $147.17 $1,614.39
Fair Value Estimate $141.07 $1,206.72
Upside to Fair Value -4.1% -25.3%
Market Cap $363.5B $239.1B
Forward P/E โ€” โ€”
EV / EBITDA 29.6x 17.9x
Price / Sales 5.5x 11.8x
Price / FCF 22.6x 20.6x
Revenue Growth YoY +5.1% +371.6%
Gross Margin 75.4% 71.5%
Operating Margin 16.7% 61.2%
Return on Equity 6.6% 93.1%
Dividend Yield 2.31% 0%
FCF Yield 4.42% 4.84%
Analyst Consensus Buy Strong Buy
Investment Thesis
MRK โ€” Merck & Co., Inc.
Merck & Co., Inc. is a global healthcare leader with two core divisions, Pharmaceuticals and Animal Health, spanning oncology, vaccines, acute hospital care, immunology, neuroscience, virology, cardiovascular and diabetes, and it employs roughly 74,000 people under CEO Robert Davis. The business quality is medium: TTM gross margin of 75.4% and TTM operating margin of 16.7% reflect a genuinely higโ€ฆ
SNDK โ€” Sandisk Corporation
Sandisk designs and manufactures NAND flash storage solutions, including SSDs, embedded memory, removable cards, USB devices, and wafers, employing roughly 11,100 people from its Milpitas, California headquarters. The business is currently generating extraordinary profitability, with TTM gross margin of 71.5%, operating margin of 61.2%, net margin of 56.5%, and ROE of 93.1%, while revenue grew 37โ€ฆ
Accumulation Zones
Metric MRK SNDK
Zone Low $105.80 $905.04
Zone High $119.91 $1,025.71
In Buy Zone? No No
โ† MRK Research    SNDK Research โ†’    All Research